Page last updated: 2024-08-24

ibandronic acid and Calcinosis

ibandronic acid has been researched along with Calcinosis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (77.78)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Åsberg, A; Bollerslev, J; Dahle, DO; Godang, K; Hartmann, A; Kile, H; Pasch, A; Smerud, KT1
Linhartova, K; Sterbakova, G; Vyskocil, V1
Omid, N; Price, PA; Than, TN; Williamson, MK1
Nguyen, TM; Price, PA; Than, TN; Williamson, MK1
Alexandersen, P; Bagger, YZ; Christiansen, C; Qin, G; Tankó, LB1
Price, PA; Roublick, AM; Williamson, MK1
De Broe, M; Ketteler, M; Persy, V1
Faus, SA; Price, PA; Williamson, MK1
Buckley, JR; Price, PA; Williamson, MK1

Trials

2 trial(s) available for ibandronic acid and Calcinosis

ArticleYear
A rapid and sustained improvement of calcification propensity score (serum T
    Clinical transplantation, 2017, Volume: 31, Issue:12

    Topics: Bone Density Conservation Agents; Calcinosis; Diphosphonates; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Survival; Humans; Ibandronic Acid; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Norway; Prognosis; Propensity Score; Prospective Studies; Risk Factors

2017
Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2005, Volume: 16, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Aortic Diseases; Bone Density; Bone Resorption; Calcinosis; Diphosphonates; Disease Progression; Double-Blind Method; Female; Humans; Ibandronic Acid; Injections, Intravenous; Long-Term Care; Middle Aged; Osteoporosis, Postmenopausal

2005

Other Studies

7 other study(ies) available for ibandronic acid and Calcinosis

ArticleYear
Bisphosphonates in calcific aortic stenosis: association with slower progression in mild disease--a pilot retrospective study.
    Cardiology, 2010, Volume: 117, Issue:3

    Topics: Aged; Alendronate; Aortic Valve Stenosis; Bone Density Conservation Agents; Calcinosis; Comorbidity; Diphosphonates; Disease Progression; Female; Hemodynamics; Humans; Ibandronic Acid; Male; Middle Aged; Osteoporosis; Pilot Projects; Retrospective Studies

2010
The amino bisphosphonate ibandronate prevents calciphylaxis in the rat at doses that inhibit bone resorption.
    Calcified tissue international, 2002, Volume: 71, Issue:4

    Topics: Animals; Anthraquinones; Arteries; Bone Resorption; Calcinosis; Calcium; Chlorides; Diphosphonates; Drug Therapy, Combination; Ferric Compounds; Ibandronic Acid; Injections, Subcutaneous; Male; Phosphates; Rats; Rats, Sprague-Dawley; Skin; Staining and Labeling; Vitamin D

2002
Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat.
    The Journal of biological chemistry, 2004, Jan-16, Volume: 279, Issue:3

    Topics: alpha-Fetoproteins; Animals; Aorta, Abdominal; Aortic Diseases; Bone Resorption; Calcinosis; Diphosphonates; Glycoproteins; Ibandronic Acid; Male; Minerals; Osteoprotegerin; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Vitamin D

2004
Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate.
    Kidney international, 2006, Volume: 70, Issue:9

    Topics: alpha-Fetoproteins; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Resorption; Calcinosis; Calcium-Binding Proteins; Diet, Protein-Restricted; Dietary Proteins; Diphosphonates; Extracellular Matrix Proteins; Ibandronic Acid; Kidney; Male; Matrix Gla Protein; Osteocalcin; Rats; Rats, Sprague-Dawley; Renal Artery; Uremia; Vascular Diseases

2006
Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels?
    Kidney international, 2006, Volume: 70, Issue:9

    Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Calcinosis; Diphosphonates; Ibandronic Acid; Kidney; Kidney Failure, Chronic; Mice; Rats; Vascular Diseases

2006
Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:5

    Topics: Alendronate; Animals; Aortic Diseases; Bone Resorption; Calcification, Physiologic; Calcinosis; Diphosphonates; Drug Administration Schedule; Etidronic Acid; Female; Humans; Ibandronic Acid; Male; Muscle, Smooth, Vascular; Osteoporosis; Rats; Rats, Sprague-Dawley; Vitamin D; Warfarin

2001
The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats.
    The Journal of nutrition, 2001, Volume: 131, Issue:11

    Topics: Animals; Calcinosis; Diphosphonates; Heart Valve Diseases; Ibandronic Acid; Kidney Diseases; Lung Diseases; Male; Rats; Rats, Sprague-Dawley; Vitamin D

2001